General Information of Drug (ID: DMM4QOJ)

Drug Name
Metadoxine Drug Info
Synonyms MG01CI; Metadoxine (oral sustained release, ADHD); Metadoxine (oral extended release, ADHD), Alcobra; Metadoxine (oral sustained release, ADHD), Alcobra
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Approved [1] , [2]
Cross-matching ID
PubChem CID
115198
CAS Number
CAS 74536-44-0
TTD Drug ID
DMM4QOJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tiagabine DMKSQG0 Epilepsy 8A60-8A68 Approved [4]
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [5]
CI-966 DM8T2KA Convulsion 8A68.Z Phase 1 [6]
NIPECOTIC ACID DMPV450 Discovery agent N.A. Investigative [7]
2,4-Diamino-butyric acid(GABA) DMAOGBP Discovery agent N.A. Investigative [8]
LU32-176B DM2YOVC Discovery agent N.A. Investigative [9]
(R)-nipecotic acid DMWGB40 Discovery agent N.A. Investigative [5]
4-Hydroxy-piperidine-3-carboxylic acid DM9VQ0T Discovery agent N.A. Investigative [10]
(R/S) EF-1500 DMYDG27 Discovery agent N.A. Investigative [4]
(R)-EF-1520 DM297MU Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA transporter GAT-1 (SLC6A1) TTPRKM0 SC6A1_HUMAN Modulator [3]

References

1 ClinicalTrials.gov (NCT02051842) Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis. U.S. National Institutes of Health.
2 Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Hum Psychopharmacol. 2011 Dec;26(8):554-9.
3 Company report (Alcobra pharma)
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 929).
5 Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates: synthesis, in vitro pharmacology, and modeling. J Med Chem. 2004 Nov 4;47(23):5620-9.
6 Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol. 1994 Oct 14;269(2):219-24.
7 Epimeric cis-decahydroquinoline-5-carboxylic acids: effects on gamma-aminobutyric acid uptake and receptor binding in vitro. J Med Chem. 1981 Jul;24(7):788-94.
8 Glycine antagonists. Synthesis, structure, and biological effects of some bicyclic 5-isoxazolol zwitterions. J Med Chem. 1986 Feb;29(2):224-9.
9 First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anti... J Pharmacol Exp Ther. 2005 Feb;312(2):866-74.
10 Hydroxy- and amino-substituted piperidinecarboxylic acids as gamma-aminobutyric acid agonists and uptake inhibitors. J Med Chem. 1982 Oct;25(10):1157-62.